| (Values in U.S. Thousands) | Mar, 2019 | Mar, 2018 | Mar, 2017 | Mar, 2016 | Sep, 2017 |
| Sales | 7,720 | 0 | 0 | 0 | -16,310 |
| Sales Growth | unch | unch | unch | +100.00% | -78.06% |
| Net Income | -6,560 | -18,040 | -18,040 | -3,720 | 9,460 |
| Net Income Growth | +63.64% | unch | -384.95% | -139.32% | unch |
Ait Therapeutics (AITB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Beyond Air Inc. is a clinical-stage medical device and biopharmaceutical company. It is engaged in developing a Nitric Oxide Generator and Delivery System. The company's principal product is AirNOvent which is in clinical stage. Beyond Air Inc., formerly known as AIT Therapeutics Inc., is based in Garden City, New York.